There’s some positive news concerning an experimental vaccine for the coronavirus.
Drugmaker Moderna has announced that all of their participants in a stage 1 trial produced antibodies for COVID-19 after receiving two doses of its mRNA vaccine.
There’s some positive news concerning an experimental vaccine for the coronavirus.
Drugmaker Moderna has announced that all of their participants in a stage 1 trial produced antibodies for COVID-19 after receiving two doses of its mRNA vaccine.
Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech..
Data from biotech company Moderna Inc shows early promising results from their COVID-19 vaccine. According to Reuters, Moderna's..